United States · FDA National Drug Code directory
Cetirizine Hydrochloride
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 30142-058_013f034c-15f9-4da2-b74c-ac999b276053
- Product NDC
- 30142-058
- Form
- TABLET, ORALLY DISINTEGRATING
- Composition / generic term
- Cetirizine Hydrochloride
- Labeler
- KROGER COMPANY
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20210308
- Source listing expiry
- 20261231
Source-listed ingredients
- CETIRIZINE HYDROCHLORIDE — 10 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 4 BLISTER PACK in 1 CARTON (30142-058-76) / 6 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK · 30142-058-76
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →